We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, N.I.H., EXTRAMURAL
REVIEW
Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.
Blood Reviews 2019 March
Myelodysplastic syndromes (MDS) consist of a heterogeneous group of myeloid neoplasms characterized by inefficient hematopoiesis, variable cytopenias and a considerable risk of progression to acute myeloid leukemia. Epidemiological assessment of MDS has been hampered by evolving diagnostic criteria and delayed classification of MDS as cancers until 2001. The poorly-understood nature of these neoplasms combined with the lack of effective therapies for decades contributed to suboptimal case ascertainment and underreporting. The annual age-adjusted incidence in the United States is approximately 4.0/100,000 persons, and the incidence substantially rises with age. Beyond age, other risk factors include male gender, obesity, smoking, and prior receipt of radiotherapy or chemotherapy, but most cases remain idiopathic in nature. The overall 5-year survival probability remains relatively poor at approximately 31% without a clear temporal improvement in outcomes despite the approval of three MDS-specific therapies since 2004 and increasing use of allogeneic hematopoietic stem cell transplantation. Better understanding of epidemiological trends of MDS will likely require incorporation of the key genetic determinants of the disease into consistent diagnostic paradigms that go beyond traditional morphologic assessments. The heterogeneity of the disease and lack of uniformly-defined genetic markers makes such a task difficult. Thorough case ascertainment and reporting efforts can provide vital insights that could inform treatment decisions and eventually improve the outcomes of patients with MDS.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app